IDEMIA announces the appointment of Erik Maris as Chairman of the Group

Maris has been an IDEMIA board member since 2022 and an advisory partner at Advent International Ltd since November 2020. As a specialist in complex and cross-border transactions, Erik has led more than a hundred operations in his career. Before joining Advent, Erik co-founded Messier Maris & Associés, and spent 19 years at Lazard France. Maris’ appointment follows Yann Delabriere’s resignation from IDEMIA’s supervisory board.

We are delighted to welcome Erik Maris as Chairman of the Board. We trust that his expertise and strategic guidance will be instrumental for IDEMIA moving forward. On behalf of the board members and IDEMIA’s Executive Committee, I want to thank Yann for his service as CEO and then chairman of the board.
Pierre Barrial, IDEMIA Group President & CEO

I couldn’t be more thrilled to take over the reins as chairman of IDEMIA’s supervisory board at an exciting time in its development. The company today finds itself in a position of strength thanks to the leadership of Pierre Barrial and his team, and I look forward to working with him and my fellow board members to pursue this momentum.
Erik Maris, Chairman of the board

NOTE TO EDITORS – Erik Maris’ biography

Erik Maris is Advisory Partner at Advent International Ltd since November 2020. Erik is also a member of the advisory board of both Espérance Banlieue and Fondation pour la Recherche Médicale.
Before joining Advent, Erik co-founded in 2010 one of the most reputable French investment banks: Messier Maris & Associés. As a specialist in complex and cross-border transactions, he conducted more than 100 operations. Prior to that, Erik spent 19 years as Managing Partner and Co-Managing Director of Lazard France, which he joined in 1991 after a first job at Morgan Stanley.
Erik is a graduate of the HEC business school in Paris.